Compare Enveric Biosciences Inc (ENVB) vs Newegg Commerce Inc (NEGG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Newegg Commerce Inc — how do they compare? Enveric Biosciences Inc trades at $1.57 (market cap $6.20M), while Newegg Commerce Inc trades at $18.51 (market cap $398.29M). The key difference: Newegg Commerce Inc is far larger — about 64.2× Enveric Biosciences Inc's market cap. Which is the better fit depends on your goals.
| ENVB | NEGG | |
|---|---|---|
Market Cap | $6.20M | $398.29M |
Sector | Health | Consumer Cyclical |
52-Week High | $17.40 | $128.09 |
52-Week Low | $1.27 | $12.87 |
Enterprise Value | $1.30M | $397.09M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.56, up 1.3% on the day, with a bullish technical signal from moving averages and strong analyst support (75% buy ratings). The company reported four consecutive quarterly earnings beats in 2025, including a positive EPS of $0.85 in Q4, while recent news highlights progress in preclinical studies for its non-hallucinogenic psychiatric drug candidate EB-003.
Despite operational losses and negative ROE/ROA, ENVB's consistent earnings surprises and advancing pipeline present speculative growth potential. Key risks include cash burn, clinical trial outcomes, and regulatory hurdles, requiring careful risk assessment by investors.
Newegg Commerce (NEGG) trades at $18.38, up 8.76% in the last session, with a bullish technical outlook and recent earnings beats. The company reported revenue of $1.44 billion for 2025, with a net loss narrowing to $4.88 million, showing improved profitability trends. Recent news highlights AI shopping features and exclusive product launches, indicating innovation efforts.
The outlook is cautiously optimistic due to earnings improvement and positive analyst sentiment, but risks include volatile cash flows, high P/E ratio, and competitive pressures in e-commerce. Institutional interest remains limited, with one analyst rating the stock a Buy as of 2026-08-12.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Newegg Commerce Inc
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.
Read more on NEGG →
